GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sino Biological Inc (SZSE:301047) » Definitions » EV-to-Revenue

Sino Biological (SZSE:301047) EV-to-Revenue : 6.86 (As of Apr. 29, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Sino Biological EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Sino Biological's enterprise value is ¥4,403.0 Mil. Sino Biological's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ¥641.7 Mil. Therefore, Sino Biological's EV-to-Revenue for today is 6.86.

The historical rank and industry rank for Sino Biological's EV-to-Revenue or its related term are showing as below:

SZSE:301047' s EV-to-Revenue Range Over the Past 10 Years
Min: 2.55   Med: 10.62   Max: 17.93
Current: 6.81

During the past 7 years, the highest EV-to-Revenue of Sino Biological was 17.93. The lowest was 2.55. And the median was 10.62.

SZSE:301047's EV-to-Revenue is ranked better than
52.9% of 1034 companies
in the Biotechnology industry
Industry Median: 7.69 vs SZSE:301047: 6.81

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-04-29), Sino Biological's stock price is ¥70.61. Sino Biological's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥4.97. Therefore, Sino Biological's PS Ratio for today is 14.22.


Sino Biological EV-to-Revenue Historical Data

The historical data trend for Sino Biological's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sino Biological EV-to-Revenue Chart

Sino Biological Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial - - 17.66 12.43 9.10

Sino Biological Quarterly Data
Dec18 Jun19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.95 11.31 10.83 9.10 -

Competitive Comparison of Sino Biological's EV-to-Revenue

For the Biotechnology subindustry, Sino Biological's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sino Biological's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sino Biological's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Sino Biological's EV-to-Revenue falls into.



Sino Biological EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Sino Biological's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=4402.983/641.652
=6.86

Sino Biological's current Enterprise Value is ¥4,403.0 Mil.
Sino Biological's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥641.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sino Biological  (SZSE:301047) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Sino Biological's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=70.61/4.966
=14.22

Sino Biological's share price for today is ¥70.61.
Sino Biological's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥4.97.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sino Biological EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Sino Biological's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Sino Biological (SZSE:301047) Business Description

Traded in Other Exchanges
N/A
Address
No. 18 Kechuang 10th Street, Room 306, Building 9, Beijing Economic and Technological Development Zon, Beijing, CHN, 100176
Sino Biological Inc is an international reagent supplier and service provider. The company specializes in recombinant protein production and antibody development. All of Sino Biological's products are independently developed and produced, including recombinant proteins, antibodies and cDNA clones.

Sino Biological (SZSE:301047) Headlines

No Headlines